文献速递冠心病高血压

运动收缩压变异性与ACS患者PCI术后长期预后的关联

[Exercise systolic blood pressure variability and long-term prognosis in patients with acute coronary syndrome].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

本研究为回顾性队列研究,纳入3 549例接受经皮冠状动脉介入治疗(PCI)并完成症状限制性踏车心肺运动试验的急性冠脉综合征(ACS)患者,中位随访24.0个月。结果显示运动收缩压变异性(eSBPV)与主要不良心血管事件(MACE)风险呈线性负相关。高eSBPV组累积无MACE生存率显著高于低eSBPV组,提示eSBPV可作为PCI术后ACS患者风险分层的功能学指标。

要点

  • 低eSBPV组(≤15.1%)MACE风险显著高于高eSBPV组(HR=1.558,P=0.002)。
  • eSBPV与MACE的负向关联不受高血压病史及运动性高血压反应状态影响。

核心结论

  • eSBPV与PCI术后ACS患者长期MACE风险呈线性负相关。
  • eSBPV作为功能学指标可有效区分不同风险层级,对出院后风险分层具有重要临床意义。

研究设计与样本

  • 回顾性队列研究,纳入2018年1月至2023年12月哈尔滨医科大学附属第二医院、广东省人民医院及鹤岗市人民医院的PCI术后ACS患者。
  • 共纳入3 549例患者,中位年龄57.0(50.0,63.0)岁,男性2 879例(81.1%)。
  • 所有患者均完成标准化症状限制性踏车心肺运动试验,中位随访24.0(18.0,36.0)个月。

主要发现

  • 随访期间共发生207例(5.8%)MACE事件。
  • 校正混杂因素后,eSBPV每增加1%与MACE风险降低相关(HR=0.969,95%CI:0.947-0.992,P=0.009)。
  • 限制性立方样条显示eSBPV与MACE呈线性负相关(总体P=0.001,非线性检验P=0.254)。
  • 高eSBPV组累积无MACE生存率显著高于低eSBPV组(log-rank P=0.001)。
  • 低eSBPV组MACE风险显著高于高eSBPV组(HR=1.558,95%CI:1.181-2.054,P=0.002)。

关键数值与推荐

  • eSBPV分组根据中位数15.1%:低eSBPV组≤15.1%,高eSBPV组>15.1%。
  • eSBPV每增加1%,MACE风险HR=0.969(95%CI:0.947-0.992,P=0.009)。
  • 低eSBPV组相对高eSBPV组MACE风险HR=1.558(95%CI:1.181-2.054,P=0.002)。

临床怎么用

  • 对于PCI术后ACS患者,心肺运动试验所得的eSBPV偏低(≤15.1%)提示长期MACE风险较高,需加强随访与二级预防管理。
  • eSBPV可作为PCI术后ACS患者出院后风险分层的功能学参考指标。

局限性

  • 回顾性队列设计可能存在选择偏倚与残余混杂。
  • 研究人群来自国内三家医院,结果外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the association between exercise systolic blood pressure variability (eSBPV) and the risk of major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI), and to evaluate its value in risk stratification. Methods: This retrospective cohort study enrolled patients with ACS who underwent PCI and subsequently completed a standardized symptom-limited cycle ergometer cardiopulmonary exercise test at the Second Affiliated Hospital of Harbin Medical University, Guangdong Provincial People's Hospital, and Hegang People's Hospital between January 2018 and December 2023. The primary endpoint was the occurrence of MACE during follow-up. Cox proportional hazards regression was used to evaluate the association between eSBPV and MACE risk, and restricted cubic spline analysis was performed to examine whether this association departed from linearity. Patients were dichotomized into low-eSBPV (≤15.1%) and high-eSBPV (>15.1%) groups based on the median eSBPV value. Kaplan-Meier curves were constructed to compare cumulative event-free survival between groups, with differences assessed using the log-rank test. Hazard ratios were estimated using Cox regression models. Subgroup analyses and interaction tests were performed according to hypertension history and hypertensive response to exercise status. Results: A total of 3 549 post-PCI ACS patients were included, with a median age of 57.0 (50.0, 63.0) years; 2 879 (81.1%) were men. Over a median follow-up of 24.0 (18.0, 36.0) months, 207 MACE events (5.8%) occurred. After adjustment for confounders, each 1% increment in eSBPV was associated with a reduction in MACE risk (HR=0.969, 95%CI: 0.947-0.992, P=0.009). Restricted cubic spline analysis demonstrated a linear inverse association between eSBPV and MACE risk (overall P=0.001, nonlinear P=0.254). Kaplan-Meier analysis showed that the high-eSBPV group had a significantly better cumulative event-free survival than the low-eSBPV group (log-rank P=0.001). Cox regression analysis further indicated that the low-eSBPV group had a higher MACE risk compared with the high-eSBPV group (HR=1.558, 95%CI: 1.181-2.054, P=0.002). Subgroup analyses revealed that the inverse association between eSBPV and MACE risk was generally consistent across different hypertension and hypertensive response to exercise statuses, with no significant interaction in the combined stratification analysis (interaction P=0.412). Conclusions: eSBPV is linearly and inversely associated with long-term MACE risk in post-PCI ACS patients and can effectively distinguish different risk levels. As a functional assessment parameter, it provides a potential novel prognostic marker for risk stratification in post-PCI ACS patients. 目的: 探讨运动收缩压变异性(eSBPV)对经皮冠状动脉介入治疗(PCI)术后急性冠脉综合征(ACS)患者长期主要不良心血管事件(MACE)发生风险的影响,并评估其风险分层价值。 方法: 本研究为回顾性队列研究,纳入2018年1月至2023年12月在哈尔滨医科大学附属第二医院、广东省人民医院及鹤岗市人民医院接受标准化症状限制性踏车心肺运动试验的PCI术后ACS患者。以随访期间发生的MACE为主要研究终点,采用Cox回归分析评估eSBPV与MACE风险的关系,通过限制性立方样条分析探索eSBPV与MACE风险是否存在非线性关联。根据eSBPV的中位数(15.1%)将研究对象分为低eSBPV组(≤15.1%)和高eSBPV组(>15.1%),绘制Kaplan-Meier生存曲线,采用log-rank检验比较组间差异,Cox回归模型估算风险比。同时按高血压病史及运动性高血压反应状态进行亚组分析及交互作用检验。 结果: 共纳入3 549例PCI术后的ACS患者,年龄57.0(50.0,63.0)岁,男性2 879例(81.1%)。随访时间24.0(18.0,36.0)个月,累计发生207例(5.8%)MACE事件。Cox回归分析结果显示,在校正混杂因素后,eSBPV与MACE呈负相关(eSBPV每增加1%,HR=0.969,95%CI:0.947~0.992,P=0.009)。限制性立方样条分析显示,eSBPV与MACE呈线性负相关(总体P=0.001,非线性检验P=0.254)。Kaplan-Meier生存曲线显示,高eSBPV组的累积无MACE生存率高于低eSBPV组(log-rank P=0.001)。进一步的Cox回归分析显示与高eSBPV组相比,低eSBPV组MACE发生风险较高(HR=1.558,95%CI:1.181~2.054,P=0.002)。亚组分析表明,eSBPV与MACE的负向关联在不同高血压及运动性高血压反应状态下总体一致,联合分层交互检验无统计学意义(交互P=0.412)。 结论: eSBPV与PCI术后ACS患者MACE发生风险呈线性负相关。该指标可为PCI术后ACS患者的预后评估提供功能学参考,对出院后的风险分层具有重要临床意义。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu, Cui, Zheng, et al. [Exercise systolic blood pressure variability and long-term prognosis in patients with acute coronary syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42736131. doi:10.3760/cma.j.cn112148-20260515-00323

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。